Emergent BioSolutions
EBS
#8180
Rank
C$0.48 B
Marketcap
C$9.50
Share price
-5.68%
Change (1 day)
-27.47%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: C$0.48 Billion

As of October 2026 Emergent BioSolutions has a market cap of C$0.48 Billion. This makes Emergent BioSolutions the world's 8180th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.48 B-46.34%
2025C$0.90 B41.24%
2024C$0.64 B289.33%
2023C$0.16 B-79.34%
2022C$0.79 B-73.18%
2021C$2.98 B-50.78%
2020C$6.05 B66.21%
2019C$3.64 B-11.89%
2018C$4.13 B41.83%
2017C$2.91 B63.1%
2016C$1.78 B-18.28%
2015C$2.18 B83.54%
2014C$1.19 B32.95%
2013C$0.89 B56.66%
2012C$0.57 B-7.1%
2011C$0.61 B-24.99%
2010C$0.82 B86.23%
2009C$0.44 B-53.59%
2008C$0.94 B532.54%
2007C$0.15 B-58.12%
2006C$0.35 B

End of Day market cap according to different sources

On Oct 29th, 2026 the market cap of Emergent BioSolutions was reported to be:

C$0.51 Billion
by Nasdaq info icon info icon
C$0.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$242.77 B 49,719.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$514.83 B 105,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$138.43 B 28,308.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
C$10.81 M-97.78%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.30 B-37.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$3.29 B 576.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$68.51 B 13,958.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel